ReFlex A+ catheter receives CE mark approval for intracranial distal access and aspiration


Reverse Medical announced that it has received CE mark for its ReFlex A+ catheter for intracranial distal access, delivery and aspiration. This catheter is uniquely designed to provide endovascular intracranial access during interventional neurovascular procedures.

ReFlex A+ provides neurovascular specialists with a line of advanced access devices that can navigate into complex neurovascular anatomy, which may enable them to treat more patients than with currently available devices.


“From my initial clinical experience, the ReFlex offered superior performance in terms of flexibility for distal navigation, support, kink resistance and aspiration. The larger internal lumen allows me to inject contrast during dual microcatheter manipulations, clearly visualising the target anatomy,” said Vitor Mendes Pereira, Reverse Medical clinical advisor. “The ReFlex A+ catheter will be useful in cases where accurate positioning is critical, such as during stent or aneurysm flow diverter implantation. The distal navigation and larger lumen size of the ReFlex enabled more effective aspiration, which should optimise acute stroke treatment.”

Jeffrey Valko, CEO of Reverse Medical said, “Intracranial endovascular access continues to expand the market for treating all neurovascular disorders. The ReFlex A+ catheter design embodies proprietary and unique design features for greater flexibility, microcatheter support, and kink resistance, with the largest internal diameter of any commercially available neurovascular access catheter. These features are particularly important for enabling a wide range of dual microcatheter support without diminishing contrast infusion, and providing a platform for focal thrombi aspiration, minimising distal emboli during thrombectomy in acute ischaemic stroke patients.”


The ReFlex A+ catheter is approved for 4, 5 and 6 French sizes, with straight and multi-purpose curve tip configurations. The company plans to immediately commence European and Asian commercialisation through prominent international distributors.


ReFlex A+ is not yet approved for sale in the USA.